Abstract
Classically, aromaticl-amino acid decarboxylase (AADC) has been regarded as an unregulated, rather uninteresting enzyme. In this review, we describe advances made during the past 10 years, demonstrating that AADC is regulated both pre- and post-translation. The significance of such regulatory mechanisms is poorly understood at present, but the presence of tissue specific control of expression raises the real possibility of AADC being involved in processes other than neurotrasmitter synthesis. We further discuss clinical and physiological situations in which such regulatory mechanisms may be important, including the intriguing possibility of AADC gene regulation being linked to that of factors thought to have a role in apoptosis and its prevention.
Similar content being viewed by others
References
Bowsher, R. R., and Henry, D. P. 1986. Aromaticl-amino acid decarboxylase: biochemistry and functional significance. Pages 33–77,in Boulton, A. A., Baker, G. B. and Yu, P. H. (eds.), Neuromethods: Series 1: Neurochemistry, Neurotransmitter Enzymes, Humana Press, Clifton, New Jersey.
Sourkes, T. L. 1979. Dopa decarboxylase. Pages 123–132,in Horn, A. S., Kauf, J., and Westerink, B. H. C. (eds.), The Neurobiology of Dopamine, Academic Press, London.
Zhu, M.-Y., and Juorio, A. V. 1995. Aromaticl-amino acid decarboxylase: characterization and functional role. Gen. Pharmacol. 26:681–696.
Boulton, A. A. 1976. Cerebral aryl alkyl aminergic mechanisms. Pages 21–39,in Usdin, E., and Sandler, M. (eds.), Trace Amines in the Brain, Marcel Dekker Inc., New York.
Paterson, I. A., Juorio, A. V., and Boulton, A. A. 1990. 2-Phenylethylamine: a modulator of catecholamine transmission in the central nervous system? J. Neurochem. 55:1827–1837.
Juorio, A. V., and Paterson, I. A. 1990. Tryptamine may couple dopaminergic and serotonergic transmission in the brain. Gen. Pharmacol. 21:613–616.
Jones, R. S. J., and Boulton, A. A. 1980. Interactions betweenp-tyramine,m-tyramine or β-phenylethylamine and dopamine on single neurons in the cortex and caudate nucleus of the rat. Can. J. Physiol. Pharmacol. 58:222–227.
Hökfelt, T., Fuxe, K., and Goldstein, M. 1973. Immunohistochemical localization of aromaticl-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine cell bodies of the rat. Brain Res. 53:175–180.
Eaton, M. J., Gudehithlu, K. P., Quach, T., Silvia, C. P., Hadjiconstantinou, M., and Neff, N. H. 1993. Distribution of aromaticl-amino acid decarboxylase mRNA in mouse brain by in situ hybridization histology. J. Comp. Neurol. 337:640–654.
Jaeger, C. B., Teitelman, G., Joh, T. H., Albert, V. R., Park, D. H., and Reis, D. J. 1983. Some neurons of the rat central nervous system contain AADC but not monoamine. Science 219:1233–1235.
Jaeger, C. B., Ruggiero, D. A., Albert, V. R., Joh, T. H., and Reis, D. J. 1984. Immunocytochemical localization of aromaticl-amino acid decarboxylase. Pages 387–408,in Björklung, A. and Hökfelt, T. (eds.), Handbook of Chemical Neuroanatomy, Vol. 2: Classical Transmitters in the CNS, Elsevier, Amsterdam.
Nagatsu, I., Sakai, M., Yoshida, M., and Nagatsu, T. 1988. Aromaticl-amino acid decarboxylase-immunoreactive neurons in and around the cerebrospinal fluid-contacting neurons of the central canal do not contain dopamine or serotonin in the mouse and rat spinal cord. Brain Res. 475:91–102.
Li, X.-M., Juorio, A. V., Paterson, I. A., Walz, W., Zhu, M.-Y., and Boulton, A. A. 1992. Gene expression of aromaticl-amino acid decarboxylase in rat cultured glial cells. J. Neurochem. 59: 1172–1175.
Juorio, A. V., Li, X.-M., Walz, W., and Paterson, I. A. 1993. Decarboxylation of L-dopa by cultured mouse astrocytes. Brain Res. 626:306–309.
Bouchard, S., and Roberge, A. G. 1979. Biochemical properties and kinetic parameters of DOPA-5HTP decarboxylase in brain, liver, and adrenals of cat. Can. J. Biochem. 57:1014–1018.
Christenson, J. G., Dairman, W., and Udenfriend, S. 1970. Preparation and properties of a homogeneous aromaticl-amino acid decarboxylase from hog kidney. Arch. Biochem. Biophys. 141: 356–367.
Lancaster, G. A., and Sourkes, T. L. 1972. Purification and properties of hog kidney 3,4-dihydroxyphenylalanine decarboxylase in the human brain. J. Neurochem. 19:1549–1559.
Ando-Yamamoto, M., Hayashi, H., Sugiyama, T., Fukui, H., Watanabe, T., and Wada, H. 1987. Purification of L-DOPA decarboxylase from rat liver and production of polyclonal and monoclonal antibodies against it. J. Biochem. 101:405–414.
Dominici, P., Tancini, B., Barra, D., and Borri Voltattomi, C. 1987. Purification and characterization of rat liver 3,4-dihydroxyphenylalanine decarboxylase. Eur. J. Biochem. 169:209–213.
Lindström, P., and Sehlin, J. 1983. Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase. Endocrinol. 112:1524–1529.
Furuzawa, Y., Ohmori, Y., and Watanabe, T. 1994. Immunohistochemical colocalization of serotonin, aromaticl-amino acid decarboxylase and polypeptide hormones in islet A- and PP-cells of the cat pancreas. J. Vet. Med. Sci. 56:911–916.
Vieira-Coelho, M. A., and Soares-da-Silva, P. 1993. Dopamine formation, from its immediate precursor 3,4-dihydroxyphenylalanine along the rat digestive tract. Fundam. Clin. Pharmacol. 7: 235–243.
Linnoila, R. I., Gazdar, A. F., Funa, K., and Becker, K. L. 1993. Long-term selective culture of hamster pulmonary endocrine cells. Anat. Rec. 236:231–240.
Pearse, A. G. E. 1969. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the apud series and the embryologic, physiologic and pathologic implications of the concept. J. Histochem. Cytochem. 17:303–313.
Pearse, A. G. E. 1974. The apud cell concept and its implication in pathology. Pathol. Ann. 31:27–34.
Lauweryns, J. M., and van Ranst, L. 1988. Immunocytochemical localization of aromaticl-amino acid decarboxylase in human, rat, and mouse bronchopulmonary and gastrointestinal cells. J. Histochem. Cytochem. 36:1181–1186.
Hayashi, M., Yamaji, Y., Kitajami, W., and Saruta, T. 1990. Aromaticl-amino acid decarboxylase activity along the rat nephron. Am. J. Physiol. 258:F28-F33.
Isaac, J., Berndt, T. J., Chinnow, S. L., Tyce, G. M., Dousa, T. P., and Knox, F. G. 1992. Dopamine enhances the phosphaturic response to parathyroid hormone in phosphate-deprived rats. J. Am. Soc. Nephrol. 2:1423–1429.
Rahman, M. K., Nagatsu, T., and Kato, T. 1981. Determination of aromaticl-amino acid decarboxylase in serum of various animals by high-performance liquid chromatography with electrochemical detection. Life Sci. 28:485–492.
Brodie, B. B., Kuntzman, R., Hirch, C. W., and Costa, E. 1962. Effects of decarboxylase inhibition on the biosynthesis of brain monoamines. Life Sci. 1:81–84.
Hadjiconstantinou, M., Rossetti, Z., Silvia, C., Krajnc, D., and Neff, N. H. 1988. Aromaticl-amino acid decarboxylase activity of the rat retina is modulated in vivo by environmental light. J. Neurochem. 51:1560–1564.
Rossetti, Z., Silvia, C. P., Krajnc, D., Neff, N. H., and Hadjiconstantinou, M. 1990. Aromaticl-amino acid decarboxylase is modulated by D1 dopamine receptors in rat retina. J. Neurochem. 54:787–791.
Rossetti, Z., Krajnc, D., Neff, N. H., and Hadjiconstantinou, M. 1989. Modulation of retinal aromaticl-amino acid decarboxylase via α2 adrenoceptors. J. Neurochem. 52:647–652.
Zhu, M.-Y., Juorio, A. V., Paterson, I. A., and Boulton, A. A. 1992. Regulation of aromaticl-amino acid decarboxylase by dopamine receptors in the rat brain. J. Neurochem. 58:636–641.
Hadjiconstantinou, M., Wemlinger, T. A., Silvia, C. P., Hubble, J. P., and Neff, N. H. 1993. Aromaticl-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J. Neurochem. 60:2175–2180.
Zhu, M.-Y., Juorio, A. V., Paterson, I. A., and Boulton, A. A. 1993. Regulation of striatal aromaticl-amino acid decarboxylase: Effects of blockade or activation of dopamine receptor. Eur. J. Pharmacol. 238:157–164.
Wessel, T. C., and Joh, T. H. 1992. Parallel upregulation of catecholamine-synthesizing enzymes in rat brain and adrenal gland: effects of reserpine and correlation with immediate early genes. Mol. Brain Res. 15:349–360.
Buckland, P. R., O'Donovan, M. C., and McGuffin, P. 1992. Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment. Psychophamacol. 108:98–102.
Masserano, J. M., Vulliet, P. R., Tank, A. W., and Weiner, N. 1989. The role of tyrosine hydroxylase in the regulation of catecholamine synthesis. Pages 427–468,in Trendeleburg, U. and Weiner, N. (eds.), Catecholamine II, Handbook of Experimental Pharmacology, Vol., 90, Springer-Verlag, Berlin, New York.
Kang, U. J., and Joh, T. H. 1990. Deduced amino acid sequence of bovine aromaticl-amino acid decarboxylase: homology to other decarboxylase. Mol. Res. 8:83–87.
Gudehithlu, K. P., Duchemin, A.-M., Silvia, C. P., Neff, N. H., and Hadjiconstantinou, M. 1992. Expression of cloned aromaticl-amino acid decarboxylase in Xenopus laevis oocytes. Neurochem. Int. 21:275–279.
Kemp, B. E., and Pearson, R. B. 1990. Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15:342–346.
Young, E. A., Neff, N. H., and Hadjiconstantinou, M. 1993. Evidence for cyclic AMP-mediated increase of aromaticl-amino acid decarboxylase activity in the striatum and midbrain. J. Neurochem.. 60:2331–2333.
Young, E. A., Neff, N. H., and Hadjiconstantinou, M. 1994. Phorbol ester administration transiently increases aromaticl-amino acid decarboxylase activity of the mouse striatum and midbrain. J. Neurochem. 63:694–697.
Berry, M. D., Hadjiconstantinou, M., and Neff, N. H. 1995. Aromaticl-amino acid decarboxylase activity is regulated via phosphorylation. Soc. Neurosci. Abs. 446:10:1135.
Johansen, P. A., Jennings, I., Cotton, R. G. H., and Kuhn, D. M. 1995. Tryptophan hydroxylase is phosphorylated by protein kinase A. J. Neurochem. 65:882–888.
Creese, I., Sibley, D. R., Hamblin, M. W., and Leff, S. E. 1983. The classification of dopamine receptors: relationship to radioligand binding. Ann. Rev. Neurosci. 6:43–71.
Kebabian, J. W., Calne, D. B. 1979. Multiple receptors for dopamine. Nature 277:93–96.
Zhu, M.-Y., Jourio, A. V., Paterson, I. A., and Boulton, A. A. 1994. Regulation of aromaticl-amino acid decarboxylase in rat striatal synaptosomes: Effects of dopamine receptor agonists and antagonists. Brit. J. Pharmacol. 112:23–30.
Bender, D. A., and Coulson, W. F. 1972. Variations in aromatic amino acid decarboxylase activity towards DOPA and 5-hydroxytryptophan caused by pH changes and denaturation. J. Neurochem. 19:2801–2810.
Sims, K. L., Davis, G. A., and Bloom, F. E. 1973. Activities of DOPA and 5-HTP decarboxylases in rat brain: Assay characteristics and distribution. J. Neurochem. 20:449–464.
Rahman, M. K., Nagatsu, T., and Kato, T. 1981. Aromaticl-amino acid decarboxylase activity in central and peripheral tissues and serum of rats withl-DOPA andl-5-hydroxytryptophan as substrates. Biochem. Pharmacol. 30:645–649.
Siow, Y. L., and Dakshinamurti, R. 1985. Effects of pyridoxine deficiency on aromaticl-amino acid decarboxylase in adult rat brain. Exp. Brain Res. 59:575–581.
Albert, V. R., Allen, J., and Joh, T. 1987. A single gene codes for aromaticl-amino acid decarboxylase in both neuronal and non-neuronal tissues. J. Biol. Chem. 262:9404–9411.
Rorsman, F., Husebye, E. S., Winqvist, O., Björk, E., Karlsson, F. A., and Kämpe, O. 1995. Aromatic-l-amino acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a β-cell autoantigen. Proc. Natl. Acad. Sci. U.S.A. 92:8626–8629.
O'Malley, K. L., Harmon, S., Moffat, M., Uhland-Smith, A., and Wong, S. 1995. The human aromaticl-amino acid decarboxzylase gene can be alternatively spliced to generate unique protein isoforms. J. Neurochem. 65:2409–2416.
Jafferji, S. S., Michell, R. H. 1976. Stimulation of phosphatidylinositol turn-over by histamine, 5-hydroxytryptamine and adrenaline in the longitudinal smooth muscle of guinea pig ileum. Biochem. Pharmacol. 25:1429–1430.
Roth, B. L., and Chuang, D.-M. 1987. Multiple mechanisms of serotonergic signal transduction. Life Sci. 41:1051–1064.
Lovenberg, W., Weissbach, H., and Udenfriend, S. 1962. Aromaticl-amino acid decarboxylase. J. Biol. Res. 237:89–93.
Bowsher, R. R., and Henry, D. P. 1983. Decarboxylation ofp-tyrosine: a potential source ofp-tyramine in mammalian tissues. J. Neurochem. 40:992–1002.
Juorio, A. V., and Yu, P. H. 1985. Effects of benzenc and other organic solvents on the decarboxylation of some brain aromatic-l-amino acids. Biochem. Pharmacol. 34:1381–1387.
Cumming, P., Kuwabara, H., Ase, A., and Gjedde, A. 1995. Regulation of DOPA decarboxylase activity in brain of living rat. J. Neurochem. 65:1381–1390.
Gjedde, A., Reith, J., Dyve, S., Leger, G., Guttman, M., Diksic, M., Evans, A., and Kuwabara, H. 1991. Dopa decarboxylase activity of the living human brain. Proc. Natl. Acad. Sci. U.S.A. 88:2721–2725.
Kuwabara, H., Cumming, P., Reith, J., Leger, G., Diksic, M., Evans, A. C., and Gjedde, A. 1993. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects. J. Cereb. Blood Flow Metab. 13:43–56.
Gjedde, A., Léger, G. C., Cumming, P., Yasuhara, Y., Evans, A. C., Guttman, M., and Kuwabara, H. 1993. Striatal L-DOPA decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis. J. Neurochem. 61: 1538–1541.
Reith, J., Benkelfat, C., Sherwin, A., Yasuhara, Y., Kuwabara, H., Andermann, F., Bachneff, S., Cumming, P., Diksic, M., Dyve, S. E., Etienne, P., Evans, A. C., Lal, S., Shevel, M., Savard, G., Wong, D. F., Chouinard, G., and Gjedde, A. 1994. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc. Natl. Acad. Sci. U.S.A. 91:11651–11654.
Jahng, J. W., Wessel, T. C., Houpt, T. A., Son, J. H., and Joh, T. H. 1996. Alternate promoters in the rat aromaticl-amino acid decarboxylase gene for neuronal and non-neuronal expression: an in situ hybridization study. J. Neurochem. 66:14–20.
Sumi-Ichinose, C., Hasegawa, S., Ichinose, H., Sawada, H., Kobayashi, K., Sakai, M., Fujii, T., Nomura, H., Nomura, T., Nagatsu, I., Hagino, Y., Fujita, K., and Nagatsu, T. 1995. Analysis of the alternative promoters that regulate tissue-specific expression of human aromaticl-amino acid decarboxylase. J. Neurochem. 64:514–524.
Hahn, S. L., Hahn, M., Kan, U. J., and Joh, T. H. 1993. Structure of the rat aromaticl-amino acid decarboxylase gene: evidence for an alternative promoter usage. J. Neurochem. 60:1058–1064.
Sumi-Ichinose, C., Ichinose, H., Takahashi, E., Hori, T., and Nagatsu, T. 1992. Molecular cloning of genomic DNA and chromosomal assigment of the gene for human aromaticl-amino acid decarboxylase, the enzyme for catecholamine and serotonin synthesis. Biochem. 31:2229–2238.
Ichinose, H., Sumi-Ichinose, C., Ohye, T., Hagino, Y., Fujita, K., and Nagatsu, T. 1992. Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromaticl-amino acid decarboxylase. Biochem. 31:11546–11550.
Krieger, M., Coge, F., Gros, F., and Thibault, J. 1991. Different mRNAs code for dopa decarboxylase in tissues of neuronal and nonneuronal origin. Proc. Natl. Acad. Sci. U.S.A. 88:2161–2165.
Albert, V. R., Lee, M. R., Bolden, A. H., Wurzburger, R. J., and Aguanno, A. 1992. Distinct promoters direct neuronal and non-neuronal expression of rat aromaticl-amino acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 89:12053–12057.
Le Van Thai, A., Coste, E., Allen, J. M., Palmiter, R. D., and Weber, M. J. 1993. Identification of a neuron-specific promoter of human aromaticl-amino acid decarboxylase gene. Mol. Brain Res. 17:227–238.
Eveleth, D. D., Gietz, R. D., Spencer, C. A., Nargang, E. E., Hodgetts, R. B., and Marsh, J. L. 1986. Sequence and structure of the dopa decarboxylase gene of Drosophila: evidence for novel RNA splicing variants. EMBO J. 5:2663–2672.
Morgan, B. A., Johnson, W. A., and Hirsh, J. 1986. Regulated splicing produces different forms of dopa decarboxylase in the central nervous system and hypoderm of Drosophila melanogaster. EMBO J. 5:3335–3342.
Scholnick, S. B., Caruso, P. A., Klemencic, J., Mastick, G. S., Mauro, C., and Rotenborg, M. 1991. Mutations within the Ddc promoter alter its neuron-specific pattern of expression. Dev. Biol. 146:423–437.
Mastick G. S., and Scholnick, S. B. 1992. Repression and activation of the Drosophila dopa decarboxylase gene in glia. Mol. Cell. Biol. 12:5659–5666.
Treacy, M. N., He, X., and Rosenfeld, M. G. 1991. I-POU: a POU-domain protein that inhibits neuron-specific gene activation. Nature 350:577–584.
Lundell, M. J., and Hirsh, J. 1992. The zfh-2 gene product is a potential regulator of neuron-specific dopa decarboxylase gene expression in Drosophila. Dev. Biol. 154:84–94.
Walz, W. 1989. Role of glial cells in the regulation of the brain ion microenvironment. Prog. Neurobiol. 33:309–333.
Chireux, M., Raynal, J. F., Le Van Thai, A., Cadas, H., Bernard, C., Martinou, I., Martinou, J. C., and Weber, M. J. 1994. Multiple promoters of human choline acetyltransferase and aromaticl-amino acid decarboxylase genes. J. Physiol. (Paris) 88:215–227.
Kim, K.-T., Park, D. H., and Joh, T. H. 1993. Parallel up-regulation of catecholamine biosynthetic enzymes by dexamethasone in PC 12 cells. J. Neurochem. 60:946–951.
Li, X.-M., Juorio, A. V., and Boulton, A. A. 1994. Induction of aromaticl-amino acid decarboxylase mRNA by interleukin-1β and prostaglandin E2 in PC12 pheochromocytoma cells. Neurochem. Res. 19:591–595.
Li, X.-M., Juorio, A. V., Paterson, I. A., Zhu, M.-Y., and Boulton, A. A. 1992. Specific irreversible MAO B inhibitors stimulate gene expression of aromaticl-amino acid decarboxylase in PC12 cells. J. Neurochem. 59:2324–2327.
Li, X.-M., Juorio, A. V., and Boulton, A. A. 1993. NSD-1015 alters the gene expression of aromaticl-amino acid decarboxylase in PC12 pheochromocytoma cells. Neurochem. Res. 18: 915–919.
Hadjiconstantinou, M., Rossetti, Z. L., Wemlinger, T. A., and Neff, N. H. 1995. Dizocilpine enhances striatal tyrosine hydroxylase and aromaticl-amino acid decarboxylase activity. Eur. J. Pharmacol. Mol. Pharmacol. Sec. 289:97–101.
Cho, S., Hadjiconstantinou, M., and Neff, N. H. 1995. Modulation of tyrosine hydroxylase and aromaticl-amino acid decarboxylase in mouse striatum after inhibition of monoamine oxidase. Soc. Neurosci. Abs. 446.9:1135.
Buckland, P. R., Spurlock, G., and McGuffin, P. 1996. Amphetamine and vigabatrin down regulate aromaticl-amino acid decarboxylase mRNA levels. Mol. Brain Res. 35:69–76.
Li, X.-M., Qi, J., Juorio, A. V., and Boulton, A. A. 1994. NGF differentially regulates the gene expression of aromaticl-amino acid decarboxylase and tyrosine hydroxylase in PC12 cells. 6th Amine Oxidase Workshop and 5th Trace Amine Conference. Saskatoon, Saskatchewan.
Ip, N. Y., Nye, S. H., Boulton, T. G., Davis, S., Taga, T., Li, Y., Birren, S. J., Yasukawa, K., Kishimoto, T., Anderson, D. J., Stahl, N., and Yancopoulos, G. D. 1992. CNTF and LIF act on neuronal cells via shared signalling pathways that involve the IL-6 signal transduction receptor component gp130. Cell 69:1121–1132.
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., and Kishimoto, T. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer gp 130. Cell 58:573–581.
Nappi, A. J., Carton, Y., and Vass, E. 1992. Reduced cellular immune competence of a temperature-sensitive dopa decarboxylase mutant strain of Drosophila melanogaster against the parasite Leptopilina boulardi. Comp. Biochem. Physiol. B. 101:453–460.
Huo, T. L., Grenader, A., Blandina, P., and Healy, D. P. 1991. Prostaglandin E2 production in rat IMCD cells. II. Possible role of locally formed dopamine. Am. J. Physiol. 261:F655-F662.
Berry, M. D., Juorio, A. V., and Paterson, I. A. 1994. Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog. Neurobiol. 44:141–161.
Li, X.-M., Juorio, A. V., and Boulton, A. A. 1995. Some new mechanisms underlying the actions of (−)-deprenyl: possible relevance to neurodegeneration, Prog. Brain Res. 106:99–112.
Yu, P. H., Davis, B. A., Zhang, X., Zuo, D. M., Fang, J., Lai, C. T., Li, X. M., Paterson, I. A., and Boulton, A. A. 1995. Neurochemical, neuroprotective and neurosescue effects of aliphaticN-methylpropargylamines: new MAO-B inhibitors without amphetamine like properties. Prog. Brain Res. 106:113–122.
Finnegan, K. T., Kratt, J. J., Irwin, I., DeLanney, L. E., and Langston, J. W. 1990. Protection against DSP-4 induced neurotoxicity by deprenyl is not related to its inhibition of MAO B. Eur. J. Pharmacol. 184:119–126.
Tatton, W. G., and Greenwood, C. E. 1991. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res. 30:666–672.
Salo, P. T., and Tatton, W. G. 1992. Deprenyl reduces cell death of motoneurons caused by axotomy. J. Neurosci. Res. 31:394–400.
Ansari, K. S., Tatton, W. G., Yu, P. H., and Kruck, T. P. A. 1993. Rescue of axotomised immature rat facial motoneurons byR(−)deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J. Neurosci. 13:4042–4053.
Shen, J., Beall, C. J., and Hirsh, J. 1993. Tissue-specific alternative splicing of the Drosophila dopa decarboxylase gene is affected by heat shock. Mol. Cell. Biol. 13:4549–4555.
Spencer, C. A., Gietz, R. D., and Hodgetts, R. B. 1986. Overlapping transcription units in the dopa decarboxylase region ofDrosophila, Nature 322:279–281.
Yuan, J., Shaam, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. 1993. The C.elegans cell death geneced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641–652.
Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314–1325.
Miura, M., Zhu, H., Rotello, R., Hartweig, E. A., and Yuan, J. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653–660.
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., and Svenson, M. 1986. Cytotoxicity of human pI7 interleukin-1 for pancreatic islets of Langerhans, Science 232:1545–1547.
Belizario, J. E., and Dinarello, C. A. 1991. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor β increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle. Cancer Res. 51:2379–2385.
Vassort, C., Riviere, M., Bruneau, G., Gros, F., Thibault, J., Levan, G., Szpirer, J., and Szpirer, C. 1993. Assignment of the rat genes coding for dopa decarboxylase (DDC) and glutamic acid decarboxylases (GAD1 and GAD2). Mamm. Genome 4:202–206.
Bruneau, G., Thibault, J., Gros, F., and Mattei, M. G. 1992. Mapping of the dopa decarboxylase gene to the 11A band of the murine genome. Biochem. Biophys. Res. Commun. 186:926–930.
Scherer, L. J., McPherson, J. D., Wasmuth, J. J., and Marsh, J. L. 1992. Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs. Genomics 13:469–471.
Bray, S. J., and Kafatos, F. C. 1991. Developmental function of Elf-1: an essential transcription factor during embryogenesis in Drosophila. Genes Dev. 5:1672–1683.
O'Keefe, S., Schouls, M., and Hodgetts, R. 1995. Epidermal cell-specific quantitation of dopa decarboxylase mRNA in Drosophila by competitive RT-PCR: an effect of Broad-Complex mutants. Dev. Genet. 16:77–84.
Hiruma, K., Carter, M. S., and Riddiford, L. M. 1995. Characterization of the dopa decarboxylase gene of Manduca sexta and its suppression by 20-hydroxyecdysone. Dev. Biol. 169:195–209.
Shen, J., and Hirsh, J. 1994. cis-Regulatory sequences responsible for alternative splicing of the Drosophila dopa decarboxylase gene. Mol. Cell. Biol. 14:7385–7393.
Hodgetts, R. B., Patel, M. S., Piorecky, J., Swan, A. D., and Spencer, C. A. 1994. Identification of a sequence motif upstream of the Drosophila dopa decarboxylase gene that enhances heterologous gene expression. Genome. 37:526–534.
Marra, M. A., Prasad, S. S., and Baillie, D. L. 1993. Molecular analysis of two genes between let-653 and let-56 in the unc-22 (IV) region of Caenorhabditis elegans. Mol. Gen. Genet. 236: 289–298.
Paterson, I. A., Juorio, A. V., Berry, M. D., and Zhu, M.-Y. 1991. Inhibition of monoamine oxidase-B by (−)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. J. Pharmacol. Exp. Ther. 258:1019–1026.
Berry, M. D., Scarr, E., Zhu, M.-Y., Paterson, I. A., and Juorio, A. V. 1994. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neuron responses to dopamine. Brit. J. Pharmacol. 113:1159–1166.
Misu, Y., Ueda, H., and Goshima, Y., 1995. Neurotransmitter-like actions of L-DOPA. Adv. Pharmacol. 32:427–459.
Young, E. A., Neff, N. H., and Hadjiconstantinou, M. 1995. Second messanger modulation of L-aromatic amino acid decarboxylase and tyrosine hydroxylase in normal and MPTP-lesioned mouse striatum. Soc. Neurosci. Abs. 491, 11:1258.
Marsden, C. D., and Parks, J. D. 1976. “On-off” effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1:292–296.
Kopin, I. J. 1993. Parkinson's disease: past, present, and future. Neuropsychopharmacol. 9:1–12.
Birkmayer, W., Riederer, P., Youdim, M. B. H., and Linauer, W. 1975. The potentiation of the anti-akinetic effect after 1-dopa treatment by an inhibitor of MAO-B, deprenyl, J. Neural Transm. 36:303–326.
Lees, A. J. 1995. Comparison of therapeutic effects and mortality data of levodopa and levedopa combined with selegiline in patients with early, mild Parkinson's disease. Brit. Med. J. 311: 1602–1607.
Klockgether, T., and Turski, L. 1990. NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine depleted rats. Ann. Neurol. 28:539–546.
Seeman, P. 1992. Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacol. 7:261–284.
Sedvall, G., and Farde, L. 1995. Chemical brain anatomy in schizophrenia. Lancet 346:743–749.
Randrup, A., and Munkvad, I. 1972. Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomol. Psychiat. 1:2–7.
Davis, K. L., Kahn, R. S., Ko, G., and Davidson, M. 1991. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiat. 148:1474–1486.
Goldstein, M., and Deutch, A. Y. 1992. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J. 6:2413–2421.
Olney, J. W., and Farber, N. B. 1995. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiat. 52:998–1007.
Watanabe, H., Imaizumi, M., Ojika, T., Abe, T., Hida, T., and Kato, K. 1994. Evaluation of biological characteristics of lung cancer by the human 28 kDa vitamin D-dependent calcium binding protein, calbindin-D28k. Jap. J. Clin. Oncol. 24:121–127.
Koh, T., Yokuta, J., Ookawa, K., Kina, T., Koshimura, K., Miwa, S., and Ariyasu, T. 1995. Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cells. Int. J. Cancer 60:843–847.
Lan, M. S., Russell, E. K., Lu, J., Johnson, B. E., and Notkins, A. L. 1993. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res. 53:4169–4171.
Gilbert, J. A., Bates, L. A., and Ames, M. M. 1995. Elevated aromatic-l-amino acid decarboxylase in human carcinoid tumors. Biochem. Pharmacol. 50:845–850.
Waymire, J. C., and Gilmer-Waymire, K. 1978. Adrenergic enzymes in cultured mouse neuroblastoma: absence of detectable aromatic-l-amino acid decarboxylase. J. Neurochem. 31:693–698.
Author information
Authors and Affiliations
Corresponding author
Additional information
Special issue dedicated to Dr. Herman Bachelard.
Rights and permissions
About this article
Cite this article
Berry, M.D., Juorio, A.V., Li, X.M. et al. Aromaticl-amino acid decarboxylase: A neglected and misunderstood enzyme. Neurochem Res 21, 1075–1087 (1996). https://doi.org/10.1007/BF02532418
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02532418